At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
Aspirin and Ketamine +1 moredrug
Likely dose
Aspirin and Ketamine 0.5mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone in Adult Patients Presenting to the ED With Acute Musculoskeletal Pain: Prospective, Randomized, Open-Label, Clinical Trial.
In Brief
A Phase 4 clinical trial evaluating Aspirin and Ketamine and Oral Ketamine for Pain. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Acute Pain is one of the most frequent chief complaints and the main reason for visiting the Emergency Department (ED). The acute pain in the ED is largely prevalent across the country with recent literature demonstrating that 61-91% of patients are admitted to the ED due to a variety of acute painful syndromes. There is a lack of good options for pain control in such settings.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20222023202420252026
Enrollment StartApr 2021
First PostedApr 2021
Primary CompletionNov 2021
Study CompletionDec 2021
TodayJul 2026
First PostedApr 27, 2021
Enrollment StartApr 22, 2021
Primary CompletionNov 30, 2021
Study CompletionDec 31, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.2 years ago
Interventions
Aspirin and Ketaminedrug
Drug: Proprietary oral formulation of 0.5mg/kg of ketamine + 324mg of aspirin
Oral Ketaminedrug
Proprietary oral formulation of 0.5mg/kg of ketamine